Disrupted genes and pathways in schizophrenia: a robust analysis of the brain and blood
These insights open new avenues for exploring key genes for SCZ, which can lead to new therapeutic targets or tools for diagnosis, potentially transforming the management of SCZ and enhancing patient care.
Authors
- Tiago Feitosa Mota (ORCID: https://orcid.org/0000-0001-6575-8208)
- Bruno B. Andrade (ORCID: https://orcid.org/0000-0001-6833-3811)
- Mariana Araújo‐Pereira (ORCID: https://orcid.org/0000-0002-1141-1580)
- Moreno Magalhães de Souza Rodrigues (ORCID: https://orcid.org/0000-0002-1594-2311)
- Artur T. L. Queiroz (ORCID: https://orcid.org/0000-0003-4908-9993)
- Eduardo R. Fukutani (ORCID: https://orcid.org/0000-0001-6326-8731)
- Rebeca Rebouças
- Henrique Q. S. Scoppetta
Institutions
- Fundação de Amparo à Pesquisa do Estado da Bahia (BR)
- Escola Bahiana de Medicina e Saúde Pública (BR)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Research Network (United States) (US)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1186/s12888-025-07524-6
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundação de Amparo à Pesquisa do Estado da Bahia
- Fundação Oswaldo Cruz